The New York Sun

Join
Politics

Could Biden Administration’s Proposal To Cover Weight Loss Drugs Lead to ‘Surge in the National Debt’?

‘I suspect that the cost of this single executive action will end up exceeding all the savings that DOGE generates put together,’ says one observer.

Mario Tama/Getty Images
The popular weight loss drug, Ozempic. Mario Tama/Getty Images
MAGGIE LITTLE
MAGGIE LITTLE

The Biden administration’s latest proposal to allow Medicare and Medicaid to cover weight loss drugs such as Ozempic and Wegovy could bring expanded coverage for millions of Americans — and with it, a hefty price tag for taxpayers. 

Have an account? Log In

To continue reading, please select:

Limited Access

Enter your email to read for FREE

Get 1 FREE article

Continue with
or
Unlimited Access

Join the Sun for a PENNY A DAY

$0.01/day for 60 days

Cancel anytime

100% ad free experience

Unlimited article and commenting access

Full annual dues ($120) billed after 60 days

View all membership options
By continuing you agree to our
Privacy Policy and Terms of Service.
MAGGIE LITTLE
MAGGIE LITTLE

Mrs. Little is from Pittsburgh and a graduate of Hillsdale College. Her work has appeared in the Wall Street Journal, the Federalist, and The Daily Signal.

Advertisement
The New York Sun

Sections

NationalForeignPoliticsArts+EconomyEducationJusticeOpinionWatchCrossword

More

MembershipBecome a FounderAdvertiseEventsNewslettersShopSubmissionsContactLegalAbout

© 2025 The New York Sun Company, LLC. All rights reserved.

Use of this site constitutes acceptance of our Terms of Use and Privacy Policy. The material on this site is protected by copyright law and may not be reproduced, distributed, transmitted, cached or otherwise used.

The New York Sun

Sign in or  Create a free account

or
By continuing you agree to our Privacy Policy and Terms of Use